Professor Shant Kumar - publications

Angeli F, Koumakis G, Chen MC, Kumar S, Delinassios JG. (2009). Role of stromal fibroblasts in cancer: promoting or impeding? Tumour Biol, 30, 109-120. eScholarID:137686 | DOI:10.1159/000218708

Al'Qteishat A, Gaffney J, Krupinski J, Rubio F, West D, Kumar S, Kumar P, Mitsios N, Slevin M. (2006). Changes in hyaluronan production and metabolism following ischaemic stroke in man. Brain, 129( Pt 8), 2158-76. eScholarID:1d31009

Warrington K, Hillarby M, Li C, Letarte M, Kumar S. (2005). Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells. Anticancer Res, 25( 3B), eScholarID:1d12048
Duff S, Saunders M, McCredie V, Kumar S, O'Dwyer S, Jayson G-. (2005). Pre-operative plasma levels of vascular endothelial growth factor A, C and D in patients with colorectal cancer. Clin Oncol (R Coll Radiol), 17( 5), eScholarID:1d30086

Quarmby, SL, Fakhoury, H., Levine, E., Barber, J., Wylie, J., Hajeer, A. H., West, CML, Stewart, A., Magee, B., Kumar, S. (2003). Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. Int J Radiat Biol, 79, 2, eScholarID:1d7359
Li C, Gardy R, Seon B, Duff S, Abdalla S, Renehan A, O'Dwyer S, Haboubi N, Kumar S. (2003). Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Br J Cancer, 88( 9), 1424-31. eScholarID:1d12123 | DOI:10.1038/sj.bjc.6600874
Duff SE, Li CS, Garland JM, Kumar S. (2003). CD105 is important for angiogenesis: evidence and potential applications. Faseb Journal, 9, 984-992. eScholarID:1d25656
Duff S, Li C, Garland J, Kumar S. (2003). CD105 is important for angiogenesis: evidence and potential applications. FASEB J, 17( 9), 984-92. eScholarID:1d12120 | DOI:10.1096/fj.02-0634rev
Li C, Issa R, Kumar P, Hampson IN, Lopez-Novoa J, Bernabeu C, Kumar S. (2003). CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci, 116( Pt 13), 2677-85. eScholarID:1d12122 | DOI:10.1242/jcs.00470
Duff S, Li C, Jeziorska M, Kumar S, Saunders M, Sherlock D, O'Dwyer S, Jayson G-. (2003). Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy. Br J Cancer, 89( 3), eScholarID:1d28683

Slevin M, Kumar S, Gaffney J. (2002). Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem, 277, 43, 41046-59. eScholarID:1d7360 | DOI:10.1074/jbc.M109443200

J Li, Garland JM, Kumar S. (2001). Re: Role of transforming growth factor beta in cancer. J Natnl Canc Inst, 93, 555-557. eScholarID:17d575

Garland JM, Kumar S, Heagerty AM. (2000). Angiogenesis in CML. Lancet, 356, 1026-1027. eScholarID:17d80
Li C, Hampson IN, Hampson L, Kumar P, Bernabeu C, Kumar S. (2000). CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. FASEB J, 14(1), eScholarID:1d3835
Li C, Guo B, Wilson PB, Stewart A, Byrne GJ, Bundred NJ, Kumar S. (2000). Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer. Int J Cancer, 89, eScholarID:1d2721
Ghellal A, Li C, Hayes M, Byrne GJ, Bundred NJ, Kumar S. (2000). Prognostic significance of TGF beta 1 and TGF beta 3 in human breast carcinoma. Anticancer Res, 20, eScholarID:1d2723

Kumar S, Ghellal A, Cheng L, Byrne GJ, Haboubi N, Wang J, Bundred NJ. (1999). Breast carcinoma: vascular density determined using CD105 antibody correlates with tumour prognosis. Cancer Research, 59, eScholarID:1d2711

Bhatnagar D, Durrington PN, Kumar S, Mackness MI, Dean J, Boulton AJM. (1995). Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM. Diabetes, 44( 4), eScholarID:1d19553

List of publications